| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.27 | 0.0004 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.26 | 0.002 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.26 | 5e-07 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.25 | 0.0007 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.21 | 0.007 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.2 | 0.007 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.2 | 0.5 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.1 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.1 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.17 | 0.1 |